Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2009

Open Access 01-12-2009 | Research article

Diagnostic accuracy of spirometry in primary care

Authors: Antonius Schneider, Lena Gindner, Lisa Tilemann, Tjard Schermer, Geert-Jan Dinant, Franz Joachim Meyer, Joachim Szecsenyi

Published in: BMC Pulmonary Medicine | Issue 1/2009

Login to get access

Abstract

Background

To evaluate the sensitivity, specificity and predictive values of spirometry for the diagnosis of chronic obstructive pulmonary disease (COPD) and asthma in patients suspected of suffering from an obstructive airway disease (OAD) in primary care.

Methods

Cross sectional diagnostic study of 219 adult patients attending 10 general practices for the first time with complaints suspicious for OAD. All patients underwent spirometry and structured medical histories were documented. All patients received whole-body plethysmography (WBP) in a lung function laboratory. The reference standard was the Tiffeneau ratio (FEV1/VC) received by the spirometric maneuver during examination with WBP. In the event of inconclusive results, bronchial provocation was performed to determine bronchial hyper-responsiveness (BHR). Asthma was defined as a PC20 fall after inhaling methacholine concentration ≤ 16 mg/ml.

Results

90 (41.1%) patients suffered from asthma, 50 (22.8%) suffered from COPD, 79 (36.1%) had no OAD. The sensitivity for diagnosing airway obstruction in COPD was 92% (95%CI 80–97); specificity was 84% (95%CI 77–89). The positive predictive value (PPV) was 63% (95%CI 51–73); negative predictive value (NPV) was 97% (95%CI 93–99). The sensitivity for diagnosing airway obstruction in asthma was 29% (95%CI 21–39); specificity was 90% (95%CI 81–95). PPV was 77% (95%CI 60–88); NPV was 53% (95%CI 45–61).

Conclusion

COPD can be estimated with high diagnostic accuracy using spirometry. It is also possible to rule in asthma with spirometry. However, asthma can not be ruled out only using spirometry. This diagnostic uncertainty leads to an overestimation of asthma presence. Patients with inconclusive spirometric results should be referred for nitric oxide (NO) – measurement and/or bronchial provocation if possible to guarantee accurate diagnosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tattersfield AE, Knox AJ, Britton JR, Hall IP: Asthma. Lancet. 2002, 360: 1313-1322. 10.1016/S0140-6736(02)11312-2.CrossRefPubMed Tattersfield AE, Knox AJ, Britton JR, Hall IP: Asthma. Lancet. 2002, 360: 1313-1322. 10.1016/S0140-6736(02)11312-2.CrossRefPubMed
2.
go back to reference Calverley PM, Walker P: Chronic obstructive pulmonary disease. Lancet. 2003, 362: 1053-1061. 10.1016/S0140-6736(03)14416-9.CrossRefPubMed Calverley PM, Walker P: Chronic obstructive pulmonary disease. Lancet. 2003, 362: 1053-1061. 10.1016/S0140-6736(03)14416-9.CrossRefPubMed
3.
go back to reference Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997, 349: 1498-1504. 10.1016/S0140-6736(96)07492-2.CrossRefPubMed Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997, 349: 1498-1504. 10.1016/S0140-6736(96)07492-2.CrossRefPubMed
6.
go back to reference Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L: Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J. 2006, 28: 945-952. 10.1183/09031936.06.00019306.CrossRefPubMed Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L: Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J. 2006, 28: 945-952. 10.1183/09031936.06.00019306.CrossRefPubMed
7.
go back to reference Buffels J, Degryse J, Heyrman J, Decramer M: Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. Chest. 2004, 125: 1394-1399. 10.1378/chest.125.4.1394.CrossRefPubMed Buffels J, Degryse J, Heyrman J, Decramer M: Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. Chest. 2004, 125: 1394-1399. 10.1378/chest.125.4.1394.CrossRefPubMed
8.
go back to reference Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ: Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000, 161: 309-329.CrossRefPubMed Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ: Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000, 161: 309-329.CrossRefPubMed
9.
go back to reference Thiadens HA, de Bock GH, Dekker FW, Huysman JA, Van Houwelingen JC, Springer MP, Postma DS: Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study. BMJ. 1998, 316: 1286-1290.CrossRefPubMedPubMedCentral Thiadens HA, de Bock GH, Dekker FW, Huysman JA, Van Houwelingen JC, Springer MP, Postma DS: Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study. BMJ. 1998, 316: 1286-1290.CrossRefPubMedPubMedCentral
10.
go back to reference Boom van den G, van Schayck CP, van Mollen MP, Tirimanna PR, den Otter JJ, van Grunsven PM, Buitendijk MJ, van Herwaarden CL, van Weel C: Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med. 1998, 158: 1730-1738.CrossRefPubMed Boom van den G, van Schayck CP, van Mollen MP, Tirimanna PR, den Otter JJ, van Grunsven PM, Buitendijk MJ, van Herwaarden CL, van Weel C: Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med. 1998, 158: 1730-1738.CrossRefPubMed
11.
go back to reference Derom E, van Weel C, Liistro G, Buffels J, Schermer T, Lammers E, Wouters E, Decramer M: Primary care spirometry. Eur Respir J. 2008, 31: 197-203. 10.1183/09031936.00066607.CrossRefPubMed Derom E, van Weel C, Liistro G, Buffels J, Schermer T, Lammers E, Wouters E, Decramer M: Primary care spirometry. Eur Respir J. 2008, 31: 197-203. 10.1183/09031936.00066607.CrossRefPubMed
12.
go back to reference Poels PJ, olde Hartman TC, Schermer TR, Albers M, van Weel C: Influence of spirometry on patient management in diagnostic studies unknown. Chest. 2006, 129: 1733-1734. 10.1378/chest.129.6.1733.CrossRefPubMed Poels PJ, olde Hartman TC, Schermer TR, Albers M, van Weel C: Influence of spirometry on patient management in diagnostic studies unknown. Chest. 2006, 129: 1733-1734. 10.1378/chest.129.6.1733.CrossRefPubMed
13.
go back to reference Ledley RS, Lusted LB: Reasoning foundations of medical diagnosis; symbolic logic, probability, and value theory aid our understanding how physicians reason. Science. 1959, 130: 9-21. 10.1126/science.130.3366.9.CrossRefPubMed Ledley RS, Lusted LB: Reasoning foundations of medical diagnosis; symbolic logic, probability, and value theory aid our understanding how physicians reason. Science. 1959, 130: 9-21. 10.1126/science.130.3366.9.CrossRefPubMed
14.
go back to reference O'Connor GT, Sox HC: Bayesian reasoning in medicine: the contributions of Lee B. Lusted, MD. Med Decis Making. 1991, 11: 107-111. 10.1177/0272989X9101100206.CrossRefPubMed O'Connor GT, Sox HC: Bayesian reasoning in medicine: the contributions of Lee B. Lusted, MD. Med Decis Making. 1991, 11: 107-111. 10.1177/0272989X9101100206.CrossRefPubMed
16.
go back to reference Schneider A, Dinant GJ, Maag I, Gantner L, Meyer FJ, Szecsenyi J: The added value of C-reactive protein to clinical signs and symptoms in patients with obstructive airway disease: results of a diagnostic study in primary care. BMC Fam Pract. 2006, 7: 28-10.1186/1471-2296-7-28.CrossRefPubMedPubMedCentral Schneider A, Dinant GJ, Maag I, Gantner L, Meyer FJ, Szecsenyi J: The added value of C-reactive protein to clinical signs and symptoms in patients with obstructive airway disease: results of a diagnostic study in primary care. BMC Fam Pract. 2006, 7: 28-10.1186/1471-2296-7-28.CrossRefPubMedPubMedCentral
17.
go back to reference Simel DL, Samsa GP, Matchar DB: Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991, 44: 763-770. 10.1016/0895-4356(91)90128-V.CrossRefPubMed Simel DL, Samsa GP, Matchar DB: Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991, 44: 763-770. 10.1016/0895-4356(91)90128-V.CrossRefPubMed
18.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Grinten van der CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Respir J. 2005, 26: 319-338. 10.1183/09031936.05.00034805.CrossRefPubMed Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Grinten van der CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Respir J. 2005, 26: 319-338. 10.1183/09031936.05.00034805.CrossRefPubMed
19.
go back to reference Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, Grinten van der CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J: Interpretative strategies for lung function tests. Eur Respir J. 2005, 26: 948-968. 10.1183/09031936.05.00035205.CrossRefPubMed Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, Grinten van der CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J: Interpretative strategies for lung function tests. Eur Respir J. 2005, 26: 948-968. 10.1183/09031936.05.00035205.CrossRefPubMed
20.
go back to reference Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, Grinten van der CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, MacIntyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G: Standardisation of the measurement of lung volumes. Eur Respir J. 2005, 26: 511-522. 10.1183/09031936.05.00035005.CrossRefPubMed Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, Grinten van der CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, MacIntyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G: Standardisation of the measurement of lung volumes. Eur Respir J. 2005, 26: 511-522. 10.1183/09031936.05.00035005.CrossRefPubMed
21.
go back to reference American Association for Respiratory Care: AARC clinical practice guideline. Body plethysmography: 2001 revision and update. Resp Care. 2001, 46: 506-513. American Association for Respiratory Care: AARC clinical practice guideline. Body plethysmography: 2001 revision and update. Resp Care. 2001, 46: 506-513.
22.
go back to reference Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS: Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995, 8: 1398-1420. 10.1183/09031936.95.08081398.CrossRefPubMed Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS: Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995, 8: 1398-1420. 10.1183/09031936.95.08081398.CrossRefPubMed
23.
go back to reference Vogelmeier C, Buhl R, Criee CP, Gillissen A, Kardos P, Kohler D, Magnussen H, Morr H, Nowak D, Pfeiffer-Kascha D, Petro W, Rabe K, Schultz K, Sitter H, Teschler H, Welte T, Wettengel R, Worth H: Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft fur Pneumologie und Beatmungsmedizin. Pneumologie. 2007, 61: e1-40. 10.1055/s-2007-959200.CrossRefPubMed Vogelmeier C, Buhl R, Criee CP, Gillissen A, Kardos P, Kohler D, Magnussen H, Morr H, Nowak D, Pfeiffer-Kascha D, Petro W, Rabe K, Schultz K, Sitter H, Teschler H, Welte T, Wettengel R, Worth H: Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft fur Pneumologie und Beatmungsmedizin. Pneumologie. 2007, 61: e1-40. 10.1055/s-2007-959200.CrossRefPubMed
24.
go back to reference Quanjer PH: EGKS: standardized lung function testing. Bull Eur Physiopathol Respir. 1983, 5: 1-92. Quanjer PH: EGKS: standardized lung function testing. Bull Eur Physiopathol Respir. 1983, 5: 1-92.
25.
go back to reference Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID: A comparison of the validity of different diagnostic tests in adults with asthma. Chest. 2002, 121: 1051-1057. 10.1378/chest.121.4.1051.CrossRefPubMed Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID: A comparison of the validity of different diagnostic tests in adults with asthma. Chest. 2002, 121: 1051-1057. 10.1378/chest.121.4.1051.CrossRefPubMed
26.
go back to reference James A, Ryan G: Testing airway responsiveness using inhaled methacholine or histamine. Respirology. 1997, 2: 97-105. 10.1111/j.1440-1843.1997.tb00061.x.CrossRefPubMed James A, Ryan G: Testing airway responsiveness using inhaled methacholine or histamine. Respirology. 1997, 2: 97-105. 10.1111/j.1440-1843.1997.tb00061.x.CrossRefPubMed
27.
go back to reference Perpina M, Pellicer C, de Diego A, Compte L, Macian V: Diagnostic value of the bronchial provocation test with methacholine in asthma. A Bayesian analysis approach. Chest. 1993, 104: 149-154. 10.1378/chest.104.1.149.CrossRefPubMed Perpina M, Pellicer C, de Diego A, Compte L, Macian V: Diagnostic value of the bronchial provocation test with methacholine in asthma. A Bayesian analysis approach. Chest. 1993, 104: 149-154. 10.1378/chest.104.1.149.CrossRefPubMed
28.
go back to reference Wilson EB: Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927, 22: 209-212. 10.2307/2276774.CrossRef Wilson EB: Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927, 22: 209-212. 10.2307/2276774.CrossRef
29.
go back to reference Altman DG, Machin D, Bryant TN, Gardner MJ: Statistics with confidence. 2000, London: BMJ Books, 2 Altman DG, Machin D, Bryant TN, Gardner MJ: Statistics with confidence. 2000, London: BMJ Books, 2
30.
go back to reference Dales RE, Vandemheen KL, Clinch J, Aaron SD: Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. Chest. 2005, 128: 2443-2447. 10.1378/chest.128.4.2443.CrossRefPubMed Dales RE, Vandemheen KL, Clinch J, Aaron SD: Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. Chest. 2005, 128: 2443-2447. 10.1378/chest.128.4.2443.CrossRefPubMed
31.
go back to reference Dales RE, Aaron SD, Vandemheen KL, Mehdizadeh A, Clinch J: The prevalence of airflow obstruction in rural primary care. Respir Med. 2006, 100: 754-759. 10.1016/j.rmed.2005.06.015.CrossRefPubMed Dales RE, Aaron SD, Vandemheen KL, Mehdizadeh A, Clinch J: The prevalence of airflow obstruction in rural primary care. Respir Med. 2006, 100: 754-759. 10.1016/j.rmed.2005.06.015.CrossRefPubMed
32.
go back to reference den Otter JJ, Reijnen GM, Bosch van den WJ, van Schayck CP, Molema J, van Weel C: Testing bronchial hyper-responsiveness: provocation or peak expiratory flow variability?. Br J Gen Pract. 1997, 47: 487-492.PubMedPubMedCentral den Otter JJ, Reijnen GM, Bosch van den WJ, van Schayck CP, Molema J, van Weel C: Testing bronchial hyper-responsiveness: provocation or peak expiratory flow variability?. Br J Gen Pract. 1997, 47: 487-492.PubMedPubMedCentral
33.
go back to reference Kunzli N, Stutz EZ, Perruchoud AP, Brandli O, Tschopp JM, Bolognini G, Karrer W, Schindler C, Ackermann-Liebrich U, Leuenberger P: Peak flow variability in the SAPALDIA study and its validity in screening for asthma-related conditions. The SPALDIA Team. Am J Respir Crit Care Med. 1999, 160: 427-434.CrossRefPubMed Kunzli N, Stutz EZ, Perruchoud AP, Brandli O, Tschopp JM, Bolognini G, Karrer W, Schindler C, Ackermann-Liebrich U, Leuenberger P: Peak flow variability in the SAPALDIA study and its validity in screening for asthma-related conditions. The SPALDIA Team. Am J Respir Crit Care Med. 1999, 160: 427-434.CrossRefPubMed
34.
go back to reference Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ: Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994, 343: 133-135. 10.1016/S0140-6736(94)90931-8.CrossRefPubMed Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ: Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994, 343: 133-135. 10.1016/S0140-6736(94)90931-8.CrossRefPubMed
35.
go back to reference Schneider A, Tilemann L, Schermer T, Gindner L, Laux G, Szecsenyi J, Meyer FJ: Diagnosing asthma in general practice with portable exhaled nitric oxide measurement – results of a prospective diagnostic study. Respir Res. 2009, 10: 15-10.1186/1465-9921-10-15.CrossRefPubMedPubMedCentral Schneider A, Tilemann L, Schermer T, Gindner L, Laux G, Szecsenyi J, Meyer FJ: Diagnosing asthma in general practice with portable exhaled nitric oxide measurement – results of a prospective diagnostic study. Respir Res. 2009, 10: 15-10.1186/1465-9921-10-15.CrossRefPubMedPubMedCentral
36.
go back to reference Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J: Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med. 2004, 140: 189-202.CrossRefPubMed Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J: Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med. 2004, 140: 189-202.CrossRefPubMed
37.
go back to reference Schermer TR, Smeele IJ, Thoonen BP, Lucas AE, Grootens JG, van Boxem TJ, Heijdra YF, van Weel C: Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J. 2008, 32: 945-952. 10.1183/09031936.00170307.CrossRefPubMed Schermer TR, Smeele IJ, Thoonen BP, Lucas AE, Grootens JG, van Boxem TJ, Heijdra YF, van Weel C: Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J. 2008, 32: 945-952. 10.1183/09031936.00170307.CrossRefPubMed
38.
go back to reference Cerveri I, Corsico AG, Accordini S, Niniano R, Ansaldo E, Anto JM, Kunzli N, Janson C, Sunyer J, Jarvis D, Svanes C, Gislason T, Heinrich J, Schouten JP, Wjst M, Burney P, de Marco R: Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax. 2008, 63: 1040-1045. 10.1136/thx.2008.095554.CrossRefPubMed Cerveri I, Corsico AG, Accordini S, Niniano R, Ansaldo E, Anto JM, Kunzli N, Janson C, Sunyer J, Jarvis D, Svanes C, Gislason T, Heinrich J, Schouten JP, Wjst M, Burney P, de Marco R: Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax. 2008, 63: 1040-1045. 10.1136/thx.2008.095554.CrossRefPubMed
39.
go back to reference Miravitlles M, de la RC, Naberan K, Lamban M, Gobartt E, Martin A: Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med. 2007, 101: 1753-1760. 10.1016/j.rmed.2007.02.019.CrossRefPubMed Miravitlles M, de la RC, Naberan K, Lamban M, Gobartt E, Martin A: Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med. 2007, 101: 1753-1760. 10.1016/j.rmed.2007.02.019.CrossRefPubMed
40.
go back to reference Schermer TR, Jacobs JE, Chavannes NH, Hartman J, Folgering HT, Bottema BJ, van Weel C: Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax. 2003, 58: 861-866. 10.1136/thorax.58.10.861.CrossRefPubMedPubMedCentral Schermer TR, Jacobs JE, Chavannes NH, Hartman J, Folgering HT, Bottema BJ, van Weel C: Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax. 2003, 58: 861-866. 10.1136/thorax.58.10.861.CrossRefPubMedPubMedCentral
41.
go back to reference Chavannes N, Schermer T, Akkermans R, Jacobs JE, van de GG, Bollen R, van Schayck O, Bottema B: Impact of spirometry on GPs' diagnostic differentiation and decision-making. Respir Med. 2004, 98: 1124-1130. 10.1016/j.rmed.2004.04.004.CrossRefPubMed Chavannes N, Schermer T, Akkermans R, Jacobs JE, van de GG, Bollen R, van Schayck O, Bottema B: Impact of spirometry on GPs' diagnostic differentiation and decision-making. Respir Med. 2004, 98: 1124-1130. 10.1016/j.rmed.2004.04.004.CrossRefPubMed
Metadata
Title
Diagnostic accuracy of spirometry in primary care
Authors
Antonius Schneider
Lena Gindner
Lisa Tilemann
Tjard Schermer
Geert-Jan Dinant
Franz Joachim Meyer
Joachim Szecsenyi
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2009
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-9-31

Other articles of this Issue 1/2009

BMC Pulmonary Medicine 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.